Web-based Adherence Information Integrated Nurse-led Monitoring Clinic
NCT04244123 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43
Last updated 2023-04-07
Summary
Non-adherence is a recognized problem with growth hormone treatment in children. In this study, we aim to utilize web-based information derived from easypod growth hormone injection devices and easypod connect devices in a nurse-led telephone clinic to improve adherence and therefore optimize growth. Our primary aim is to test height SDS change over a 12 month period. Our secondary aims are to test adherence, acceptance/satisfaction and qualitative assessment.
Conditions
- Short Stature
- Growth Hormone Treatment
Interventions
- COMBINATION_PRODUCT
-
integrated information and nurse led telephone clinic
combining web-based information from easypod connect with nurse led telephone clinic
Sponsors & Collaborators
-
Manchester University NHS Foundation Trust
lead OTHER_GOV
Principal Investigators
-
Indi Banerjee · Manchester University NHS Foundation Trust
Eligibility
- Min Age
- 1 Year
- Max Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-01-24
- Primary Completion
- 2021-12-13
- Completion
- 2023-01-05
- FDA Drug
- Yes
Countries
- United Kingdom
Study Locations
More Related Trials
-
Nutrients and Hormones: Effects in Boys With Disordered Growth
NCT00139451 ·Status: COMPLETED ·Phase: PHASE2
-
Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents
NCT00156143 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
NCT06948214 ·Status: RECRUITING ·Phase: PHASE3
-
Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy
NCT03672617 ·Status: COMPLETED
-
The Dosage Exploration Study of PEG-rhGH for Treating Short Stature in Prepubertal and Pubertal Children
NCT06768411 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Short Stature Related Distress
NCT01246219 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Body Composition in Children Treated With Growth Hormone for the Indication of Isolated Non-acquired Growth Hormone Deficiency.
NCT07333521 ·Status: RECRUITING
-
A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency
NCT04615273 ·Status: COMPLETED ·Phase: PHASE3
-
Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients
NCT00570011 ·Status: COMPLETED ·Phase: PHASE3
-
Biological Age in Children With GH Deficiency Undergoing Hormone Replacement Therapy
NCT06294860 ·Status: COMPLETED
-
Evolution of the Quality of Life of Short Statured Children Treated With Growth Hormone : Evaluation at Adult Size
NCT05195437 ·Status: COMPLETED
-
National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
NCT00097513 ·Status: COMPLETED
-
Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin
NCT00488124 ·Status: COMPLETED ·Phase: PHASE2
-
Detection of Difficulties and Improvement Compliance to Growth Hormone Treatment
NCT03005561 ·Status: UNKNOWN ·Phase: NA
-
Growth Hormone Therapy and Bone Quality in Pediatric Osteoporosis
NCT00757393 ·Status: COMPLETED ·Phase: PHASE3
-
Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
NCT00163189 ·Status: COMPLETED ·Phase: PHASE3
-
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore)
NCT02015273 ·Status: COMPLETED
-
An Observational Study on Treatment Compliance by Children Treated With Growth Hormone
NCT01068639 ·Status: WITHDRAWN
-
Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children
NCT06103513 ·Status: RECRUITING ·Phase: PHASE3
-
Comparison of a Needle-free Injection Method With a Needle-syringe Injection Method
NCT00990340 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency
NCT01502124 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
NCT02781727 ·Status: COMPLETED ·Phase: PHASE3
-
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
NCT07221851 ·Status: RECRUITING ·Phase: PHASE3
-
Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone
NCT01327924 ·Status: COMPLETED
-
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in France
NCT01291394 ·Status: COMPLETED